Succinate Dehydrogenase in Lung Cancer: from Molecular Mechanisms to Clinical Implications
OncoTargets and Therapy · 2026-10 · Volume 19 · 1-16
DOI: 10.2147/ott.s629223 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift OncoTargets and Therapy, 2026-10. Verfasst von Yali Du und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, 610041, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, 610041, People's Republic of China.
- Division of Internal Medicine, Institute of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu, 610041, People's Republic of China.
Zitieren
APA
Du, Y., He, L., Guo, Y., Zhang, Y., & He, J. (2026). Succinate Dehydrogenase in Lung Cancer: from Molecular Mechanisms to Clinical Implications. OncoTargets and Therapy, Volume 19, 1-16. https://doi.org/10.2147/ott.s629223
Vancouver
Du Y, He L, Guo Y, Zhang Y, He J. Succinate Dehydrogenase in Lung Cancer: from Molecular Mechanisms to Clinical Implications. OncoTargets and Therapy. 2026;Volume 19:1-16. doi:10.2147/ott.s629223
BibTeX
@article{Du2026,
author = {Du, Yali and He, Lulu and Guo, Yi and Zhang, Yuchen and He, Jianping},
title = {Succinate Dehydrogenase in Lung Cancer: from Molecular Mechanisms to Clinical Implications},
journal = {OncoTargets and Therapy},
year = {2026},
volume = {Volume 19},
pages = {1--16},
doi = {10.2147/ott.s629223}
}
EUVIMED